• Melanoma
Name No. Patient Profile Purpose
CA045-001 18-51

Previously untreated or unresectable or Metastatic Melanoma

The purpose of the study is to test the effectiveness (how well the drug works), safety, and tolerability of the investigational drug called NKTR-214, when combined with nivolumab versus nivolumab given alone in participants with previously untreated melanoma skin cancer that is either unable to be surgically removed or has spread.


  • Melanoma
Name No. Patient Profile Purpose
R2810-ONC-1788 18-50

Cutaneous Squamous Cell Carcinoma (High Risk)

The primary objective of the study is to compare disease-free survival (DFS) of patients with high-risk cutaneous squamous cell carcinoma (CSCC) treated with adjuvant cemiplimab, versus those treated with placebo, after surgery and radiation therapy (RT).


  • Melanoma
Name No. Patient Profile Purpose
CA209-8FC 19-13

Patients with complete resection of Stage IIIa/b/c/d or Stage IV Melanoma

The purpose of this trial is to compare whether there is a difference in treatment outcome for patients treated with Nivolumab manufactured by Process C or the newly developed comparable drug manufactured by Process D.